Founded in 1968 as a part of the Air Liquide Group, Cryopal is a major player in the design, manufacture and commercialization of tanks for oxygen therapy and for the cryopreservation and transport of biological samples in the fields of health and medical research, pharmaceuticals industry, genetics and animal nutrition.
Cryopal markets in 90 countries a dozen of product lines besides accessories and spare parts for maintenance purposes. The Group stands out for the quality and reliability of its various product lines, which are all classified as medical devices.
With the support of Initiative & Finance, the management team led by Olivier Lartigue wishes to accelerate the company’s development by investing in its R&D capacities, its production tool, and its commercial presence, both on the main European and export markets while further develop its service offering.
Turnover at acquisition
Type of investment
Staff at acquisition
Sector of activity